May 21, 2018 / 12:13 PM / 6 months ago

BRIEF-Inovio Opens Trial To Test Its VGX-3100 Drug In HPV Patients

May 21 (Reuters) - Inovio Pharmaceuticals Inc:

* INOVIO OPENS PHASE 2 TRIAL FOR VGX-3100 IN THIRD INDICATION TO TREAT HPV – THE NO. 1 SEXUALLY TRANSMITTED DISEASE

* INOVIO PHARMACEUTICALS INC - STUDY IS PLANNING TO ENROLL APPROXIMATELY 24 PATIENTS AND WILL ADMINISTER AT LEAST THREE DOSES OF VGX-3100 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below